ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 199.7m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Interest Income Expense
-$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Interest Income Expense
-€2.2B
CAGR 3-Years
-33%
CAGR 5-Years
-6%
CAGR 10-Years
-12%
Merck KGaA
XETRA:MRK
Interest Income Expense
-€74m
CAGR 3-Years
34%
CAGR 5-Years
28%
CAGR 10-Years
10%
MPH Health Care AG
XETRA:93M1
Interest Income Expense
€31.5m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Interest Income Expense
-€64.3m
CAGR 3-Years
-99%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Interest Income Expense
-€2.7m
CAGR 3-Years
-203%
CAGR 5-Years
-221%
CAGR 10-Years
N/A
No Stocks Found

ATAI Life Sciences NV
Glance View

Market Cap
199.7m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
0.02 USD
Overvaluation 98%
Intrinsic Value
Price

See Also

What is ATAI Life Sciences NV's Interest Income Expense?
Interest Income Expense
-1.7m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Interest Income Expense amounts to -1.7m USD.

Back to Top